
Joon Lee
Stock Analyst at UBS
(4.97)
# 87
Out of 5,136 analysts
547
Total ratings
56.7%
Success rate
33.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joon Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASND Ascendis Pharma | Rated: Buy | $269 → $315 | $271.73 | +15.92% | 2 | Nov 13, 2026 | |
| CRSP CRISPR Therapeutics AG | Reiterated: Hold | $52 | $40.37 | +28.81% | 27 | Nov 9, 2026 | |
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $88 → $81 | $28.01 | +189.18% | 2 | Nov 9, 2026 | |
| PRAX Praxis Precision Medicines | Reiterated: Buy | $706 | $310.27 | +127.54% | 31 | Nov 9, 2026 | |
| RAPP Rapport Therapeutics | Reiterated: Buy | $64 | $24.82 | +157.86% | 3 | Nov 5, 2026 | |
| SLDB Solid Biosciences | Reiterated: Buy | $20 | $6.48 | +208.64% | 13 | Nov 5, 2026 | |
| BMRN BioMarin Pharmaceutical | Reiterated: Buy | $88 | $57.99 | +51.75% | 16 | Nov 3, 2026 | |
| REGN Regeneron Pharmaceuticals | Reiterated: Buy | $978 → $1,068 | $952.40 | +12.14% | 2 | Nov 2, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterated: Buy | $354 → $329 | $159.73 | +105.97% | 2 | Oct 30, 2026 | |
| BBIO BridgeBio Pharma | Reiterated: Buy | $92 | $77.36 | +18.92% | 2 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $60.97 | +47.61% | 13 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $94 | $26.80 | +250.75% | 45 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $11 | $2.87 | +283.28% | 44 | Oct 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $109 | $44.21 | +146.55% | 1 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $76 → $48 | $21.88 | +119.38% | 2 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $76 → $16 | $15.90 | +0.63% | 30 | Oct 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.87 | - | 22 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.63 | - | 16 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $525 | $537.79 | -2.38% | 16 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $50 | $45.73 | +9.34% | 30 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $69.22 | - | 38 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.86 | - | 29 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $46.53 | - | 3 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $239.77 | - | 26 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $137.01 | - | 37 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.00 | n/a | 8 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.06 | n/a | 24 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $950.95 | n/a | 38 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $10.03 | n/a | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $4.82 | n/a | 10 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $65 | $6.77 | n/a | 5 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $4 | $3.61 | n/a | 4 | Dec 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $12.75 | n/a | 1 | Aug 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $2.60 | n/a | 1 | Jun 19, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $15.13 | n/a | 1 | Aug 8, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $18.67 | n/a | 1 | Aug 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $0.8609 | n/a | 1 | Jul 28, 2014 |
Ascendis Pharma
Nov 13, 2026
Rated: Buy
Price Target: $269 → $315
Current: $271.73
Upside: +15.92%
CRISPR Therapeutics AG
Nov 9, 2026
Reiterated: Hold
Price Target: $52
Current: $40.37
Upside: +28.81%
Ionis Pharmaceuticals
Nov 9, 2026
Reiterated: Buy
Price Target: $88 → $81
Current: $28.01
Upside: +189.18%
Praxis Precision Medicines
Nov 9, 2026
Reiterated: Buy
Price Target: $706
Current: $310.27
Upside: +127.54%
Rapport Therapeutics
Nov 5, 2026
Reiterated: Buy
Price Target: $64
Current: $24.82
Upside: +157.86%
Solid Biosciences
Nov 5, 2026
Reiterated: Buy
Price Target: $20
Current: $6.48
Upside: +208.64%
BioMarin Pharmaceutical
Nov 3, 2026
Reiterated: Buy
Price Target: $88
Current: $57.99
Upside: +51.75%
Regeneron Pharmaceuticals
Nov 2, 2026
Reiterated: Buy
Price Target: $978 → $1,068
Current: $952.40
Upside: +12.14%
Alnylam Pharmaceuticals
Oct 30, 2026
Reiterated: Buy
Price Target: $354 → $329
Current: $159.73
Upside: +105.97%
BridgeBio Pharma
Oct 30, 2026
Reiterated: Buy
Price Target: $92
Current: $77.36
Upside: +18.92%
Oct 30, 2026
Reiterated: Buy
Price Target: $90
Current: $60.97
Upside: +47.61%
Oct 29, 2026
Reiterated: Buy
Price Target: $94
Current: $26.80
Upside: +250.75%
Oct 28, 2026
Rated: Buy
Price Target: $11
Current: $2.87
Upside: +283.28%
Oct 15, 2026
Rated: Buy
Price Target: $109
Current: $44.21
Upside: +146.55%
Oct 15, 2026
Reiterated: Buy
Price Target: $76 → $48
Current: $21.88
Upside: +119.38%
Oct 14, 2026
Initiated Coverage: Hold
Price Target: $76 → $16
Current: $15.90
Upside: +0.63%
Mar 17, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.87
Upside: -
Mar 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.63
Upside: -
Mar 11, 2026
Reiterated: Buy
Price Target: $525
Current: $537.79
Upside: -2.38%
Mar 9, 2026
Reiterated: Hold
Price Target: $50
Current: $45.73
Upside: +9.34%
Mar 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $69.22
Upside: -
Mar 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.86
Upside: -
Feb 26, 2026
Reiterated: Buy
Price Target: n/a
Current: $46.53
Upside: -
Feb 25, 2026
Reiterated: Buy
Price Target: n/a
Current: $239.77
Upside: -
Feb 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $137.01
Upside: -
Nov 6, 2025
Reiterated: Buy
Price Target: n/a
Current: $3.00
Upside: n/a
Nov 5, 2025
Reiterated: Buy
Price Target: n/a
Current: $4.06
Upside: n/a
Aug 1, 2025
Reiterated: Buy
Price Target: n/a
Current: $950.95
Upside: n/a
Dec 4, 2024
Rated: Buy
Price Target: n/a
Current: $10.03
Upside: n/a
Nov 14, 2023
Reiterated: Buy
Price Target: $18
Current: $4.82
Upside: n/a
Jan 17, 2023
Reiterated: Buy
Price Target: $100 → $65
Current: $6.77
Upside: n/a
Dec 8, 2022
Reiterated: Hold
Price Target: $7 → $4
Current: $3.61
Upside: n/a
Aug 8, 2019
Reiterated: Buy
Price Target: $10
Current: $12.75
Upside: n/a
Jun 19, 2019
Initiated Coverage: Buy
Price Target: $20
Current: $2.60
Upside: n/a
Aug 8, 2014
Reiterated: Buy
Price Target: n/a
Current: $15.13
Upside: n/a
Aug 7, 2014
Reiterated: Buy
Price Target: $33
Current: $18.67
Upside: n/a
Jul 28, 2014
Reiterated: Buy
Price Target: $14
Current: $0.8609
Upside: n/a